Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1 - Induced plasticity of adult blood vessels

被引:100
作者
Baffert, F
Thurston, G
Rochon-Duck, M
Le, T
Brekken, R
McDonald, DM
机构
[1] Univ Calif San Francisco, Dept Anat, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA
[3] Univ Texas, SW Med Ctr, Dallas, TX USA
[4] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
angiogenesis; angiopoietin-1; microvasculature; vascular endothelial growth factor; vascular endothelial growth factor receptor-2;
D O I
10.1161/01.RES.0000125295.43813.1F
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang1) are essential for vascular development, but this dependency has been assumed not to persist into adult life. In this study, we report that after 10 days of systemic treatment of 4-, 8-, and 16-week-old mice with VEGF-Trap, an inhibitor of VEGF, the number of capillaries in the tracheal mucosa was reduced by 39%, 28%, and 14%, respectively. The magnitude of the reduction decreased with age (r(2)=0.6, P<0.001), but was still significant at 16 weeks. A corresponding age-related decrease in vascular endothelial growth factor receptor-2 (VEGFR-2) immunoreactivity suggests that diminished VEGFR-2 expression may contribute to resistance to VEGF signaling inhibition. VEGF-Trap further reduced VEGFR-2 expression in tracheal capillaries. By comparison, systemic treatment with adenovirus encoding Ang1 led to a significant enlargement of tracheal venules with little age effect (64%, 56%, and 49% increase in diameter at 10 days). When Ang1 was given in combination with VEGF-Trap, tracheal vessels presented the typical response to each factor, showing that the Ang1 effect was not VEGF-mediated, yet Ang1 seems to have a protective effect, as judged by prevention of VEGF-Trap-induced reduction in tracheal capillaries in the oldest group. Together, these findings indicate that VEGF and Ang1 participate in blood vessel survival and plasticity in adult life.
引用
收藏
页码:984 / 992
页数:9
相关论文
共 32 条
[1]   VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY [J].
ALON, T ;
HEMO, I ;
ITIN, A ;
PEER, J ;
STONE, J ;
KESHET, E .
NATURE MEDICINE, 1995, 1 (10) :1024-1028
[2]   Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal [J].
Benjamin, LE ;
Keshet, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8761-8766
[3]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[4]  
Benjamin LE, 1998, DEVELOPMENT, V125, P1591
[5]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[6]   Loss of HIF-2 and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice [J].
Compernolle, V ;
Brusselmans, K ;
Acker, T ;
Hoet, P ;
Tjwa, M ;
Beck, H ;
Plaisance, S ;
Dor, Y ;
Keshet, E ;
Lupu, F ;
Nemery, B ;
Dewerchin, M ;
Van Veldhoven, P ;
Plate, K ;
Moons, L ;
Collen, D ;
Carmeliet, P .
NATURE MEDICINE, 2002, 8 (07) :702-710
[7]   Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169
[8]   VASCULAR-PERMEABILITY FACTOR VASCULAR ENDOTHELIAL GROWTH-FACTOR - AN IMPORTANT MEDIATOR OF ANGIOGENESIS IN MALIGNANCY AND INFLAMMATION [J].
DVORAK, HF ;
DETMAR, M ;
CLAFFEY, KP ;
NAGY, JA ;
VANDEWATER, L ;
SENGER, DR .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) :233-235
[9]   Inhibition of vascular endothelial growth factor in the treatment of colorectal cancer [J].
Fernando, NH ;
Hurwitz, HI .
SEMINARS IN ONCOLOGY, 2003, 30 (03) :39-50
[10]   THE REGULATION OF BLOOD-VESSEL GROWTH BY VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
FERRARA, N ;
HEINSOHN, H ;
WALDER, CE ;
BUNTING, S ;
THOMAS, GR .
CARDIAC GROWTH AND REGENERATION, 1995, 752 :246-256